Cervical cancer patients in the country are set to receive affordable treatments soon, with the introduction of high-tech Brachytherapy facilities at the Bangabandhu Sheikh Mujib Medical University (BSMMU).
A Brachytherapy machine, worth Tk2.5 crore and donated by the Indian government as a gesture of goodwill, will be inaugurated by Indian High Commissioner to Bangladesh Pankaj Saran at the BSMMU oncology department today.
Brachytherapy – also known as internal radiotherapy – allows a physician to use a higher total dose of radiation to treat a smaller area and in a shorter time than is possible with external beam radiation treatment for cancer patients.
Sources at the BSMMU said although the machine is being inaugurated now, its operation will begin after at least a month’s time when the radiation source materials would arrive.
Professor Saidur Rahman, registrar of the university, credited BSMMU Vice-Chancellor Prof Dr Pran Gopal Datta for taking the initiative to introduce the latest cancer treatment facilities at the hospital.
Sources said the country currently has four active Brachytherapy machines – one at National Cancer Institute and three more at private hospitals (United, Delta and Khaja Yunus hospitals).
The cost of each round of Brachytherapy treatment is around Tk2,000 at the public hospital and between Tk10,000 to Tk12,000 at the private hospitals. The BSMMU would provide a more affordable option with only Tk1,000 for every round of therapy.
Cervical cancer is the most common form of cancer among Bangladeshi women, with most patients (over 80%) being diagnosed at stage II and stage III. Radiotherapy (both teletherapy and brachytherapy) is the most important modality of treatment at these stages.
Cancer specialists of the BSMMU have said Brachytheraphy can also be used for treatment of various other cancers including cancers of the prostate, head and neck, breast, gallbladder, uterus, vagina, lung, rectum and eye.
The oncology department of the BSMMU, however, will initially use this machine only for the treatment of cervical cancer.
In developing countries, the prevalence of cervical cancer is related to many risk factors such as early marriage, sexual activities at an early age, low socio-economic condition and high incidence of sexually transmitted diseases and human papillomavirus (HPV) infection.
Prof Dr Sarwar Alam, chairman and head of oncology department of the BSMMU, told the Dhaka Tribune that the cancer of the cervix is potentially preventable and curable.
Women who remain most susceptible to the development of cervical cancer are those who do not receive any screening at all, he said.
It was immensely important to have a national health policy regarding preemptive screening, diagnosing and treating of pre-cancerous condition of the cervix, Dr Alam said.



